Cargando…
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes
Iron overload (IO) reflected by elevated ferritin is associated with increased mortality in myelodysplastic syndromes (MDS), however, ferritin is an imperfect metric. Elevated labile plasma iron correlates with clinical outcomes and transferrin saturation (TSAT) >80%, but is not readily measurabl...
Autores principales: | Teichman, Jennifer, Geddes, Michelle, Zhu, Nancy, Keating, Mary-Margaret, Sabloff, Mitchell, Christou, Grace, Leber, Brian, Khalaf, Dina, St-Hilaire, Eve, Finn, Nicholas, Shamy, April, Yee, Karen W.L., Storring, John M., Nevill, Thomas J., Delage, Robert, Elemary, Mohamed, Banerji, Versha, Houston, Brett, Mozessohn, Lee, Chodirker, Lisa, Zhang, Liying, Siddiqui, Mohammed, Parmentier, Anne, Leitch, Heather A., Buckstein, Rena J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890030/ https://www.ncbi.nlm.nih.gov/pubmed/35979720 http://dx.doi.org/10.3324/haematol.2022.280723 |
Ejemplares similares
-
Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer
por: Petrone, Giulia, et al.
Publicado: (2022) -
Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes
por: Fischer, Melissa A., et al.
Publicado: (2022) -
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
por: Karantanos, Theodoros, et al.
Publicado: (2022) -
Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation
por: Muto, Tomoya, et al.
Publicado: (2023) -
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
por: Clichet, Valentin, et al.
Publicado: (2023)